Financhill
Back

Arcutis Biotherapeutics Vs. Biogen Industry Stock Comparison

Sell
39

ARQT
Arcutis Biotherapeutics

Last Price:
10.25
Seasonality Move:
47.83%
Sell
30

BIIB
Biogen

Last Price:
168.32
Seasonality Move:
8.35%
Sell
39
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $10.84. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

  • The current Biogen [BIIB] share price is $172.03. The Score for BIIB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • BIIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $10.84
    The current trend is moderately bullish and ARQT is experiencing slight selling pressure.

BIIB Stock Price Chart

What is Biogen's stock price today?

  • The Biogen share price today is $172.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIIB is experiencing slight selling pressure.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 70.45 Buy
Chaikin Money Flow: -549607 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.47 - 10.03) Buy
Bollinger Bands (100): (8.89 - 10.43) Buy

BIIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.93 Sell
Relative Strength Index (14 RSI): 31.05 Sell
Chaikin Money Flow: -503219 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (175.8 - 188.26) Sell
Bollinger Bands (100): (185.61 - 219.85) Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.62 Buy
20-day SMA: 9.12 Buy
50-day SMA: 9.7 Buy
200-day SMA: 9.31 Buy
8-day EMA: 9.93 Buy
20-day EMA: 9.48 Buy
50-day EMA: 9.49 Buy
200-day EMA: 9.09 Buy

BIIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 173.93 Sell
20-day SMA: 181.12 Sell
50-day SMA: 189.35 Sell
200-day SMA: 211.86 Sell
8-day EMA: 174.93 Sell
20-day EMA: 179.6 Sell
50-day EMA: 188.22 Sell
200-day EMA: 211.51 Sell

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.

Biogen Earnings Growth & BIIB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.27 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biogen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):